For patients with stage IA NSCLC, lung resections, including lobectomy and segmentectomy, are associated with improved long-term survival compared with wedge resection.

Among patients with stage IA non-small cell lung cancer, long-term survival was better with lobectomy or segmentectomy vs.

New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections. Read further on Dynamite News: ...

The study analysed outcomes for more than 32,000 stage 1A NSCLC patients using data from the STS General Thoracic Surgery ...

There is a poor prognosis for lung cancer when surgery is not an option, a reasonable morbidity and mortality related to standard resection despite an ill population, and a modest decline in lung ...

New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, ...

For early-stage NSCLC, lobar resection has been the gold standard since 1995 with publication of the LCSG trial. Given that ...

Research at the 2025 STS Annual Meeting indicates anatomical lung resections such as lobectomy are linked to improved survival rates in early-stage NSCLC. Data analysis from over 32,000 patients shows ...

with radical resection of lung cancer combined with targeted drug therapy, and 1 (0.45%) with molecular targeted therapy. The Univariate COX model found that whether the patients underwent lung cancer ...

There is a commercial access agreement for durvalumab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...